Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 14.5 | 11.7 | 10.4 | 13.8 | 7.1 | 2.1 |
| Revenue growth | 23.6% | 12.6% | -24.7% | 93.4% | 246.4% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 14.5 | 11.7 | 10.4 | 13.8 | 7.1 | 2.1 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 81.6 | 44.9 | 33.1 | 25.5 | 20.8 | 11.9 |
| General and administrative | 49.5 | 32.4 | 29.2 | 14.6 | 8.1 | 6.4 |
| EBIT | -116.7 | -65.6 | -52.0 | -26.3 | -21.7 | -16.2 |
| EBIT margin | -806.6% | -561.0% | -500.1% | -190.6% | -304.7% | -787.0% |
| Pre-tax income | -114.2 | -68.5 | -51.7 | -30.9 | -22.2 | -16.3 |
| Income taxes | -1.5 | -1.7 | -0.7 | -0.3 | -0.4 | 0.0 |
| Tax rate | 1.3% | 2.4% | 1.4% | 0.8% | 1.8% | 0.1% |
| Net income | -112.7 | -66.8 | -51.0 | -30.6 | -21.8 | -16.3 |
| Net margin | -779.3% | -571.2% | -491.0% | -221.8% | -306.1% | -789.3% |
| |
| Diluted EPS | ($3.80) | ($2.67) | ($2.66) | ($2.77) | ($49.78) | ($48.81) |
| Shares outstanding (diluted) | 29.7 | 25.1 | 19.1 | 11.0 | 0.4 | 0.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|